Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics

BMC Clinical Pharmacology

Volumn 9, Issue , 2009, Pages

  Zuluaga, Andres F ^a   Agudelo, Maria ^a   Rodriguez, Carlos A ^a   Vesga, Omar ^a  

^a University of Antioquia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMIKACIN; GENERIC DRUG; GENTAMICIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACCURACY; ARTICLE; BACILLUS SUBTILIS; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; COST CONTROL; DRUG APPROVAL; DRUG DOSAGE FORM; DRUG POTENCY; DRUG SCREENING; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; MEDICAL LITERATURE; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; CHEMISTRY; CULTURE MEDIUM; DRUG EFFECT; HUMAN; METHODOLOGY; PHARMACOKINETICS; REGRESSION ANALYSIS; REPRODUCIBILITY;

ANTI-BACTERIAL AGENTS; BACILLUS SUBTILIS; CULTURE MEDIA; HUMANS; INJECTIONS, INTRAVENOUS; MICROBIAL SENSITIVITY TESTS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; THERAPEUTIC EQUIVALENCY;

EID: 60849129812     PISSN: None     EISSN: 14726904     Source Type: Journal    
DOI: 10.1186/1472-6904-9-1     Document Type: Article

References (43)

1. The Global Antibacterials Market: R&D Pipelines, Market Analysis and Competitive Landscape Arrowhead Publishers 2007, 1-126. http://www.arrowheadpublishers.com/reports/infectious-disease/ the-global-antibacterials-mark/#
2. Gerbino PP Joseph AS Multisource drugs: Implications and concerns in the geriatric population Hosp Pharm 1993, 28:96-2. 10125706
3. Marketing Authorization of Pharmaceutical Products with Special Reference to Multisource (Generics) Products: A Manual for Drug Regulatory Authorities http://www.who.int/prequal/info_general/documents/ WHO_DMP_RGS_98_5_R.pdf
4. Kirking DM Ascione FJ Perspectives on generic pharmaceuticals: Some conclusions J Am Pharm Assoc (Wash) 2001, 41:826-828. 11765106
5. Dettelbach HR A time to speak out on bioequivalence and therapeutic equivalence J Clin Pharmacol 1986, 26:307-308. 2871052
6. Senn S In the blood: Proposed new requirements for registering generic drugs Lancet 1998, 352:85-86. 10.1016/S0140-6736(98)85007-1 9672271
7. Generic Drugs Med Lett Drugs Ther 2002, 44:89-90. 12405134
8. Rozendaal J Fake antimalaria drugs in Cambodia Lancet 2001, 357-890. 10.1016/S0140-6736(05)71830-4 11265991
9. Csillag C Epidemic of counterfeit drugs causes concern in Brazil Lancet 1998 352 553 10.1016/S0140-6736(05)79267-9 9716071
10. Dondorp AM Newton PN Mayxay M Van DW Smithuis FM Yeung S Petit A Lynam AJ Johnson A Hien TT McGready R Farrar JJ Looareesuwan S Day NP Green MD White NJ Fake antimalarials in Southeast Asia are a major impediment to malaria control: Multinational cross-sectional survey on the prevalence of fake antimalarials Trop Med Int Health 2004, 9:1241-1246. 10.1111/ j.1365-3156.2004.01342.x 15598255
11. Taylor RB Shakoor O Behrens RH Everard M Low AS Wangboonskul J Reid RG Kolawole JA Pharmacopoeial quality of drugs supplied by Nigerian pharmacies Lancet 2001, 357:1933-1936. 10.1016/S0140-6736(00)05065-0 11425415
12. Welage LS Kirking DM Ascione FJ Gaither CA Understanding the scientific issues embedded in the generic drug approval process J Am Pharm Assoc (Wash) 2001, 41: 856-867. 11765111
13. Hewitt W Microbiological Assay for Pharmaceutical Analysis: A Rational Approach Llandysul, UK, CRC Press 2003, 1-260.
14. Souza MJ Bittencourt CF Souza FP Microbiological assay for enrofloxacin injection Int J Pharm 2004, 271:287-291. 10.1016/j.ijpharm.2003.11.012 15129996
15. Li L Miles MV Hall W Carson SW An improved micromethod for vancomycin determination by high-performance liquid chromatography Ther Drug Monit 1995, 17:366-370. 10.1097/00007691-199508000-00009 7482691
16. Pfaller MA Krogstad DJ Granich GG Murray PR Laboratory evaluation of five assay methods for vancomycin: Bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay J Clin Microbiol 1984, 20:311-316. 271319 6386852
17. Yeo KT Traverse W Horowitz GL Clinical performance of the EMIT vancomycin assay Clin Chem 1989 35 1504 1507 2667803
18. Fong KL Ho DH Bogerd L Pan T Brown NS Gentry L Bodey GP Sensitive radioimmunoassay for vancomycin Antimicrob Agents Chemother 1981, 19:139-143. 181372 7247352
19. Heatley NG A method for the assay of penicillin Biochem J 1944, 38:61-65. 1258024 16747749
20. United States Pharmacopeia Convention United States Pharmacopeia Rockville, MD.: United States Pharmacopeia Convention 2002, 1083-1084.
21. Salgado HR Tozo GC Microbiological assay for cefoxitin sodium in dosage form J AOAC Int 2007, 90:452-455. 17474516
22. Roy J Pharmaceutical impurities - a mini-review AAPS PharmSciTech 2002, 3:E6. 10.1208/pt030206 12916943
23. Klein RD Edberg SC Lorian V Applications, significance of, and methods for the measurement of antimicrobial concentrations in human body fluids Antibiotics in laboratory medicine Philadelphia, Lippincott Williams & Wilkins Victor Lorian 2005
24. Antibiotic Assay Media Franklin Lakes, NJ, USA: Becton Dickinson and Company 1999, 38-45.
25. Isenberg HD Clinical Microbiology Procedures Handbook Washington DC, USA, ASM Press 2004
26. Cushnie TP Hamilton VE Chapman DG Taylor PW Lamb AJ Aggregation of Staphylococcus aureus following treatment with the antibacterial flavonol galangin J Appl Microbiol 2007, 103:1562-1567. 10.1111/ j.1365-2672.2007.03393.x 17953567
27. Bennett JV Brodie JL Benner EJ Kirby WM Simplified, accurate method for antibiotic assay of clinical specimens Appl Microbiol 1966, 14:170-177. 546645 4959982
28. Mark H Application of an improved procedure for testing the linearity of analytical methods to pharmaceutical analysis J Pharm Biomed Anal 2003, 33:7-20. 10.1016/S0731-7085(03)00346-7 12946526
29. Welch BL The significance of the difference between two means when the population variances are unequal Biometrika 1938, 29:350-362. http://www.jstor.org/stable/2332010
30. Glantz SA Primer of Biostatistics New York, McGraw-Hill Companies 2006
31. Petersen HH Nielsen JP Jensen AL Heegaard PM Evaluation of an enzyme-linked immunosorbent assay for determination of porcine haptoglobin J Vet Med A Physiol Pathol Clin Med 2001, 48:513-523. 11765808
32. Food and Drug Administration Guidance for Industry: Bioanalytical Method Validation Rockville 2001 http://www.fda.gov/CDER/GUIDANCE/4252fnl.pdf
33. Bottcher S von BH Hoppe-Tichy T Benz C Sonntag HG An HPLC assay and a microbiological assay to determine levofloxacin in soft tissue, bone, bile and serum J Pharm Biomed Anal 2001, 25:197-203. 10.1016/ S0731-7085(00)00478-7 11275428
34. Mendez AS Weisheimer V Oppe TP Steppe M Schapoval EE Microbiological assay for the determination of meropenem in pharmaceutical dosage form J Pharm Biomed Anal 2005, 37:649-653. 10.1016/j.jpba.2004.11.030 15797784
35. Joos B Ledergerber B Flepp M Bettex JD Luthy R Siegenthaler W Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urine Antimicrob Agents Chemother 1985, 27:353-356. 176276 3158274
36. British Pharmacopoeia Commission British Pharmacopoeia London, Bernan Press 2007
37. Sutton S Validation of alternative microbiology methods for product testing: Quantitative and qualitative assays Pharmaceutical technology 2005, 29:118-122.
38. Simon HJ Yin EJ Microbioassay of antimicrobial agents Appl Microbiol 1970, 19:573-579. 376740 4986725
39. Humphrey JH Lightbown JW A general theory for plate assay of antibiotics with some practical applications J Gen Microbiol 1952, 7:129-143. 13011264
40. Somerville AL Wright DH Rotschafer JC Implications of vancomycin degradation products on therapeutic drug monitoring in patients with end-stage renal disease Pharmacotherapy 1999, 19:702-707. 10.1592/ phco.19.9.702.31548 10391415
41. Harris CM Kopecka H Harris TM Vancomycin: Structure and transformation to CDP-I J Am Chem Soc 1983, 105:6915-6922. 10.1021/ja00361a029
42. Sheldrick GM Jones PG Kennard O Williams DH Smith GA Structure of vancomycin and its complex with acetyl-D-alanyl-D-alanine Nature 1978, 271:223-225. 10.1038/271223a0 622161
43. Harris CM Kopecka H Harris TM The stabilization of vancomycin by peptidoglycan analogs J Antibiot (Tokyo) 1985, 38:51-57. 3972728